Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | PARP1 | P09874 | 8/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.46 |
| ▸ | MELK | Q14680 | 1/20 | 0.46 |
| ▸ | STK24 | Q9Y6E0 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | TYMS | P04818 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20086 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL27034083 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Potassium SCHEMBL1315293 | 0.98 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Water SCHEMBL18317911 | 0.98 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL1316616 | 0.98 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL25429670 | 0.98 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL1315230 | 0.98 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Hydrochloric Acid SCHEMBL7117065 | 0.98 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL49588 | 0.98 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Lithium SCHEMBL1315235 | 0.98 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025067689-A1 | 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR THE TREATMENT OF INFECTIONS WITH AN RNA VIRUS | METRIOPHARM AG (CH) | 2025-04-03 | — | — | WO | claimed |
| EP-4499062-A1 | COMBINATION OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE AND A FUMARIC ACID ESTER | MetrioPharm AG (CH) | 2025-02-05 | — | — | EP | claimed |
| CN-116075306-B | Compounds for the treatment of coronavirus infections | 麦翠奥制药公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118973563-A | Combination of 5-amino-2, 3-dihydro-1, 4-phthalazinedione with fumarate | 麦翠奥制药公司 | 2024-11-15 | — | — | CN | claimed |
| EP-4460312-A1 | COMBINATION OF BUDESONIDE AND 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE | MetrioPharm AG (CH) | 2024-11-13 | — | — | EP | claimed |
| CN-118785909-A | Use of 5-amino-2, 3-dihydro-1, 4-phthalazinediones for the treatment of congenital muscular dystrophy | 麦翠奥制药公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118510521-A | Combination of budesonide and 5-amino-2, 3-dihydro-1, 4-phthalazinedione | 麦翠奥制药公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118369100-A | Combination of 5-amino-2, 3-dihydro-1, 4-phthalazinedione with 6' -methoxy cinchonine-9-ol for the treatment of coronavirus infections | 麦翠奥制药公司 | 2024-07-19 | — | — | CN | claimed |
| CN-111587243-B | Method for solubilising 5-amino-2, 3-dihydro-1, 4-phthalazinediones | 麦翠奥制药公司 | 2024-04-12 | — | — | CN | claimed |
| CN-111107839-B | Microneedle array with color transition indicator | LTS勒曼治疗系统股份公司 | 2023-11-10 | — | — | CN | claimed |
| EP-4164651-A1 | COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONS | MetrioPharm AG (CH) | 2023-04-19 | — | — | EP | claimed |
| CN-115916258-A | Glucocorticoid reducing agent | 麦翠奥制药公司 | 2023-04-04 | — | — | CN | claimed |
| EP-4125802-A1 | 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF ACUTE LUNG INJURY | MetrioPharm AG (CH) | 2023-02-08 | — | — | EP | claimed |
| EP-4096628-A1 | USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY DISEASES | MetrioPharm AG (CH) | 2022-12-07 | — | — | EP | claimed |
| EP-4096669-A1 | USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE TREATMENT OF RARE CHRONIC INFLAMMATORY PULMONARY DISEASES | MetrioPharm AG (CH) | 2022-12-07 | — | — | EP | claimed |
| WO-2022245969-A1 | IRON ION DETECTING ASPIRATING DENTAL CARTRIDGE SYSTEM | ACIES MEDICAL LLC (US) | 2022-11-24 | — | — | WO | claimed |
| CN-115052602-A | Use of 5-amino-2, 3-dihydro-1, 4-phthalazinediones in the treatment of rare chronic inflammatory lung diseases | 麦翠奥制药公司 | 2022-09-13 | — | — | CN | claimed |
| CN-109071461-B | Method for preparing 5-amino-2, 3-dihydrophthalazine-1, 4-diketone crystal | 麦翠奥制药公司 | 2022-06-21 | — | — | CN | claimed |
| WO-2022117221-A1 | LUMINOL FOR THE PROPHYLAXIS AND THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2022-06-09 | — | — | WO | claimed |
| WO-2022120383-A1 | METHOD FOR DETECTION OF VIRAL INFECTIONS USING SPLIT ENZYMES | BRIGHAM YOUNG UNIVERSITY (US) | 2022-06-09 | — | — | WO | claimed |